Private, no accountPrivacy details: browsing privately, no account needed
You're browsing privately, no account needed. Your region stays in this session and your precise location is never stored.What we store
S. 2754 · 109th CongressIn committee

Alternative Pluripotent Stem Cell Therapies Enhancement Act

Latest action. Rules CommitteeThe House committee that writes the terms of debate, the 'rule', for each major bill: how long debate runs and which amendments are allowed.Read the full definition (opens a new tab) Resolution H. Res. 924 Reported to House. Rule provides for consideration of S. 2754 with 1 hour of general debate. previous questionThe House motion that cuts off debate and forces an immediate vote. A simple majority is enough, which is why the House has no filibuster.Read the full definition (opens a new tab) shall be considered as ordered without intervening motions except motion to recommitThe House minority's last shot before final passage: a motion to send the bill back to committee, sometimes with instructions to change it.Read the full definition (opens a new tab). Measure will be considered read. Bill is closed to amendments. · July 18, 2006

Live record from Congress.gov, updated as the official record changes.
What this bill would do
Official summary · Congressional Research Service

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Alternative Pluripotent Stem Cell Therapies Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo.

Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

Written by analysts at the Congressional Research Service and published on Congress.gov, not by Civibrief. Summarized at the "Passed Senate without amendment" stage on July 18, 2006. It describes the bill, it is not the legal text.

Status
Introduced
May 5, 2006
In committee
July 18, 2006
Passed a chamber
Cleared Congress
Enacted
Where this sits in the process
Common questions
Composed from the official record
Where is it in the process, and what happens next?

4 steps remain before this bill could become law.

The record's latest action, on July 18, 2006: Rules Committee Resolution H. Res. 924 Reported to House. Rule provides for consideration of S. 2754 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit. Measure will be considered read. Bill is closed to amendments.

  1. Clearing the committees it was referred to, and being scheduled for a floor vote
  2. Passage by the Senate
  3. Passage by the House
  4. The President's signature. If the President vetoes it, two-thirds of both chambers must vote to override.
How likely is it to become law?

Civibrief does not forecast outcomes and this page has no opinion about this one. What the record supports is a base rate, which is a fact about the whole pile, not a prediction about this measure.

In the 109th Congress (2005-06), 482 of the 10,701 bills and joint resolutions introduced became law, about 4.5 percent. That count covers every measure at every stage, including the many that never left committee.

This one is not there yet: 4 steps are still outstanding, listed above.

Has anyone actually voted on it?

No. No roll call in this Congress cites this measure. That is the ordinary outcome: most measures never reach a recorded floor vote, and a committee ends most of them simply by not acting.

A vote is not the only thing that happens to a measure. Hearings, markups, and referrals are all recorded actions, and none of them is a vote of the full chamber.

Who is behind it?

RICK SANTORUM (R-PA) introduced it on May 5, 2006, and 5 members have since signed on as cosponsors.

They are 5 Republicans.

Cosponsoring is a formal signature on the text. It is not a commitment to vote for the measure, it does not bind anyone's party, and a long list of cosponsors is a measure of attention rather than of prospects.

How long has it been in play?

It was introduced on May 5, 2006, 7433 days ago. The most recent recorded action was 7359 days ago, on July 18, 2006.

Measures do not carry over. Anything the 109th Congress has not finished by January 3, 2007 dies when the term ends, and has to be introduced again from the start in the next Congress.

Every answer above is assembled from this measure's own record on Congress.gov and from published counts of what Congress has passed before. Civibrief does not predict outcomes and takes no position on any measure.

Vote history

  1. Senate
    In committee, no floor vote yet
  2. House
    Awaits Senate passage
  3. President
    Awaits both chambers
No recorded votes yet
No roll call in this Congress cites this bill. Most bills die in committee without ever reaching a recorded floor vote.